Latest Breaking News On - Clinical development updates - Page 1 : comparemela.com

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

29.05.2024 - Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year .

Chau chengExchange commissionNeurology clinical development updatesDue to roivant sciences ltdGeneral clinical development updatesEndocrinology clinical development updatesImmunovant incClinical development updatesThyroid eye diseaseInsulin growth factorFiscal fourth quarter ended marchFiscal year ended marchPrivate securities litigation reform actAnnual reportRoivant sciences

Valerio Therapeutics : Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Valerio Therapeutics : Reports Full Year 2023 Financial Results and Provides Clinical Development Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Clinical development updatesDownload pressTherapeutics reports full yearProvides clinical development

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChan yingSan diegoStephen jasperContinent pharmaceuticals co ltdExchange commissionDrug administrationNational medical products administrationGyre therapeutics incGyre pharmaceuticalsPreclinical development updatesClinical development updatesJiangsu wangao pharmaceuticals co ltdChief executive officerIshak scoring systemNon alcoholic steatohepatitis

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNoord hollandMatthew philippeWilliamh lewisMichael davidsonHannah deresiewiczJen gordonClinical development updatesDevelopment rd expensesSecurities exchange commissionNewamsterdam pharma companyNeither the companyNewamsterdam pharma companynv nasdaqCompany contactCompany phase

Catalyst Biosciences : Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K

Catalyst Biosciences : Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChan yingSan diegoStephen jasperExchange commissionNational medical products administrationClinical development updatesJiangsu wangao pharmaceuticals co ltdGyre therapeutics incContinent pharmaceuticals co ltdPreclinical development updatesGyre pharmaceuticalsDrug administrationGyre therapeutics reports first quarterProvides business updateChief executive officer